TY - JOUR
T1 - Factors Associated with Postprocedural Diffusion-Weighted Imaging–Positive Lesions in Endovascular Treatment for Unruptured Cerebral Aneurysms
AU - Tokunaga, Keisuke
AU - Hatano, Taketo
AU - Nakahara, Ichiro
AU - Ishii, Akira
AU - Higashi, Eiji
AU - Kamata, Takahiko
AU - Funakoshi, Yusuke
AU - Hashikawa, Takuro
AU - Takita, Wataru
AU - Chihara, Hideo
AU - Ando, Mitsushige
AU - Sadamasa, Nobutake
AU - Kitazono, Takanari
AU - Nagata, Izumi
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/10
Y1 - 2019/10
N2 - Background: In endovascular treatment for cerebral aneurysms, the appearance of asymptomatic thromboembolic lesions detected by postprocedural diffusion-weighted imaging (DWI) can be a surrogate marker for estimating the potential risk of symptomatic thromboembolism. The aim of this study was to clarify factors associated with postprocedural DWI-positive lesions in endovascular treatment for unruptured cerebral aneurysms. Methods: Patients with untreated unruptured cerebral aneurysms undergoing endovascular treatment were consecutively enrolled. Treatment techniques were classified into simple coiling, balloon-assisted coiling, stent-assisted coiling, and flow-diverter placement. Head magnetic resonance imaging was performed within 3 months before and 24 hours after the procedure to assess the appearance of DWI-positive lesions. Results: Among 376 aneurysms in 355 patients that were analyzed, 232 (61.7%) had postprocedural DWI-positive lesions. In univariate analyses, age (P = 0.001), dome size (P < 0.001), neck size (P < 0.001), treatment technique (P = 0.029), and total procedural time (P < 0.001) were significantly associated with postprocedural DWI-positive lesions. In the multiple logistic regression model, older age (odds ratio, 1.33; 95% confidence interval, 1.10–1.60; P = 0.003; per decade), flow-diverter placement (odds ratio, 4.93; 95% confidence interval, 1.33–20.92; P = 0.016; compared with simple coiling), and longer procedural time (odds ratio, 1.66; 95% confidence interval, 1.26–2.21; P < 0.001; per hour) were associated with postprocedural DWI-positive lesions. Conclusions: Older age, flow-diverter placement, and longer procedural time were associated with postprocedural DWI-positive lesions in endovascular treatment for unruptured cerebral aneurysms.
AB - Background: In endovascular treatment for cerebral aneurysms, the appearance of asymptomatic thromboembolic lesions detected by postprocedural diffusion-weighted imaging (DWI) can be a surrogate marker for estimating the potential risk of symptomatic thromboembolism. The aim of this study was to clarify factors associated with postprocedural DWI-positive lesions in endovascular treatment for unruptured cerebral aneurysms. Methods: Patients with untreated unruptured cerebral aneurysms undergoing endovascular treatment were consecutively enrolled. Treatment techniques were classified into simple coiling, balloon-assisted coiling, stent-assisted coiling, and flow-diverter placement. Head magnetic resonance imaging was performed within 3 months before and 24 hours after the procedure to assess the appearance of DWI-positive lesions. Results: Among 376 aneurysms in 355 patients that were analyzed, 232 (61.7%) had postprocedural DWI-positive lesions. In univariate analyses, age (P = 0.001), dome size (P < 0.001), neck size (P < 0.001), treatment technique (P = 0.029), and total procedural time (P < 0.001) were significantly associated with postprocedural DWI-positive lesions. In the multiple logistic regression model, older age (odds ratio, 1.33; 95% confidence interval, 1.10–1.60; P = 0.003; per decade), flow-diverter placement (odds ratio, 4.93; 95% confidence interval, 1.33–20.92; P = 0.016; compared with simple coiling), and longer procedural time (odds ratio, 1.66; 95% confidence interval, 1.26–2.21; P < 0.001; per hour) were associated with postprocedural DWI-positive lesions. Conclusions: Older age, flow-diverter placement, and longer procedural time were associated with postprocedural DWI-positive lesions in endovascular treatment for unruptured cerebral aneurysms.
UR - http://www.scopus.com/inward/record.url?scp=85068857330&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068857330&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2019.06.114
DO - 10.1016/j.wneu.2019.06.114
M3 - Article
C2 - 31247348
AN - SCOPUS:85068857330
SN - 1878-8750
VL - 130
SP - e457-e462
JO - World Neurosurgery
JF - World Neurosurgery
ER -